99% Savings - Buy Just @1 Rs X
Glimitab Mp 1 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Diabetes. Secondary and off-label uses of Glimitab Mp 1 Tablet have also been mentioned below.
The right dosage of Glimitab Mp 1 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Glimitab Mp 1 Tablet include Nausea or vomiting, Diarrhoea, Headache. Apart from the aforementioned side effects, Glimitab Mp 1 Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Glimitab Mp 1 Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Glimitab Mp 1 Tablet is Unknown for pregnant women and Safe for women who are breastfeeding. Warnings related to Glimitab Mp 1 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Glimitab Mp 1 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Glimitab Mp 1 Tablet in conditions like Liver Disease, Kidney Disease.
Besides this, Glimitab Mp 1 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Glimitab Mp 1 Tablet is not safe while driving, and is is not addictive in nature.
Glimitab Mp 1 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glimitab Mp 1 Tablet safe for pregnant women?
The effects of Glimitab Mp on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Glimitab Mp 1 Tablet safe during breastfeeding?
Glimitab Mp is safe for breastfeeding women.
What is the effect of Glimitab Mp 1 Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Glimitab Mp. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Glimitab Mp 1 Tablet on the Liver?
Glimitab Mp may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glimitab Mp 1 Tablet on the Heart?
Glimitab Mp is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Glimitab Mp 1 Tablet unless your doctor advises you to do so -
Is this Glimitab Mp 1 Tablet habit forming or addictive?
Forming a habit of Glimitab Mp 1 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Glimitab Mp 1 Tablet can make you feel drowsy.
Is it safe?
Yes, but consume Glimitab Mp 1 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Glimitab Mp 1 Tablet in mental disorders is not effective.
Interaction between Food and Glimitab Mp 1 Tablet
There is no information on the effects of taking Glimitab Mp 1 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glimitab Mp 1 Tablet
Information about the interaction of Glimitab Mp 1 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033